Showing results (1561-1570 of 1,877) with videos related to

Sort By:
Pageof 188
Acta Obstetricia Et Gynecologica Scandinavica|January 27, 2025
Hypothermic machine perfusion in uterus transplantation in a porcine model: A proof of concept and the first results in graft preservationCarla Héléna Sousa, Marion Mercier, Nathalie Rioux-Leclercq, et al.
Molecular Biology and Evolution|April 18, 2020
A Whole-Genome Scan for Association with Invasion Success in the Fruit Fly Drosophila suzukii Using Contrasts of Allele Frequencies Corrected for Population StructureLaure Olazcuaga, Anne Loiseau, Hugues Parrinello, et al.
Genome Medicine|August 10, 2021
The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variabilityJennifer Derrien, Catherine Guérin-Charbonnel, Victor Gaborit, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2019
Whole-Genome Sequencing for Drug Resistance Profile Prediction in <i>Mycobacterium tuberculosis</i>Sebastian M Gygli, Peter M Keller, Marie Ballif, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 31, 2021
[Vaginal LASER therapy for genito-urinary disorders: A systematic review and statement from the Committee for Female Urology and Pelviperineology of the French Association of Urology]J Klap, S Campagne-Loiseau, N Berrogain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2025
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple MyelomaAnil Aktas Samur, Jill Corre, Srikanth Talluri, et al.
Blood|June 14, 2024
NK cells with adhesion defects and reduced cytotoxic functions are associated with a poor prognosis in multiple myelomaEve Blanquart, Rüçhan Ekren, Bineta Rigaud, et al.
Nature Communications|February 9, 2021
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myelomaMehmet Kemal Samur, Mariateresa Fulciniti, Anil Aktas Samur, et al.
Experimental Hematology|September 3, 2013
Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patientsMauricette Michallet, Mohamad Sobh, Jean El-Cheikh, et al.
Neurocritical Care|June 10, 2022
Neurocritical Care Performance Measures Derived from Electronic Health Record Data are Feasible and Reveal Site-Specific Variation: A CHoRUS Pilot ProjectSophie E Ack, Shamelia Y Loiseau, Guneeti Sharma, et al.
Pageof 188